Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (TEVA)
NYSE:TEVA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 16.54B | $ 15.85B | $ 14.93B | $ 15.88B | $ 16.66B |
| Gross Profit | $ 8.06B | $ 7.64B | $ 6.97B | $ 7.59B | $ 7.73B |
| Operating Income | $ -303.00M | $ 433.00M | $ -2.20B | $ 1.72B | $ -3.57B |
| EBITDA | $ 4.43B | $ 1.56B | $ -925.00M | $ 4.41B | $ 4.61B |
| Net Income | $ -1.64B | $ -559.00M | $ -2.45B | $ 417.00M | $ -3.99B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.30B | $ 3.23B | $ 2.80B | $ 2.17B | $ 2.18B |
| Total Assets | $ 39.33B | $ 43.48B | $ 44.01B | $ 47.67B | $ 50.64B |
| Total Debt | $ 18.08B | $ 20.15B | $ 21.56B | $ 23.46B | $ 26.40B |
| Net Debt | $ 14.78B | $ 16.93B | $ 18.76B | $ 21.29B | $ 24.22B |
| Total Liabilities | $ 33.61B | $ 35.35B | $ 35.41B | $ 36.42B | $ 39.58B |
| Stockholders' Equity | $ 5.37B | $ 7.51B | $ 7.80B | $ 10.28B | $ 10.03B |
| Cash Flow | |||||
| Free Cash Flow | $ 2.05B | $ 842.00M | $ 1.04B | $ 236.00M | $ 638.00M |
| Operating Cash Flow | $ 2.55B | $ 1.37B | $ 1.59B | $ 798.00M | $ 1.22B |
| Investing Cash Flow | $ -565.67M | $ 968.00M | $ 656.00M | $ 1.52B | $ 863.00M |
| Financing Cash Flow | $ -1.74B | $ -1.91B | $ -1.49B | $ -2.17B | $ -1.89B |